tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SHPH Stock Latest News

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
Press ReleasesShuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
8d ago
SHPH
Shuttle Pharmaceuticals announces publication of manuscript on SP-1-303
PremiumThe Fly
Shuttle Pharmaceuticals announces publication of manuscript on SP-1-303
8d ago
SHPH
Shuttle Pharmaceuticals Welcomes New CFO Timothy Lorber
PremiumCompany Announcements
Shuttle Pharmaceuticals Welcomes New CFO Timothy Lorber
1M ago
8K
SHPH
Shuttle Pharmaceuticals appoints Timothy Lorber as CFO
PremiumThe Fly
Shuttle Pharmaceuticals appoints Timothy Lorber as CFO
1M ago
SHPH
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
PremiumPress Releases
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
1M ago
SHPH
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
PremiumPress ReleasesShuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
2M ago
SHPH
Shuttle Pharmaceuticals provides Q1 update
PremiumThe Fly
Shuttle Pharmaceuticals provides Q1 update
2M ago
SHPH
Shuttle Pharma Provides First Quarter 2024 Corporate Update
PremiumPress Releases
Shuttle Pharma Provides First Quarter 2024 Corporate Update
2M ago
SHPH
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1×1 Meetings on Thursday, May 2, 2024
PremiumPress Releases
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1×1 Meetings on Thursday, May 2, 2024
3M ago
SHPH
Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
PremiumThe Fly
Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
4M ago
SHPH
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
PremiumPress Releases
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
4M ago
SHPH
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
PremiumPress Releases
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
5M ago
SHPH
Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding
PremiumCompany AnnouncementsShuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding
6M ago
8K
SHPH
Shuttle Pharmaceuticals intends to pursue rights offering
PremiumThe Fly
Shuttle Pharmaceuticals intends to pursue rights offering
6M ago
SHPH
Shuttle Pharmaceuticals Bolsters Investor Relations with New Partnership
PremiumCompany Announcements
Shuttle Pharmaceuticals Bolsters Investor Relations with New Partnership
6M ago
8K
SHPH
Shuttle Pharmaceuticals Acquires Promising Prostate Cancer Technology
PremiumCompany Announcements
Shuttle Pharmaceuticals Acquires Promising Prostate Cancer Technology
6M ago
8K
SHPH
Shuttle Pharmaceuticals approved by FDA for Phase 2 trial of Ropidoxuridine
PremiumThe Fly
Shuttle Pharmaceuticals approved by FDA for Phase 2 trial of Ropidoxuridine
7M ago
SHPH
Shuttle Pharmaceuticals submits IND application to U.S. FDA for Ropidoxuridine
PremiumThe Fly
Shuttle Pharmaceuticals submits IND application to U.S. FDA for Ropidoxuridine
8M ago
SHPH
Shuttle Pharmaceuticals licenses IP for prostate cancer biomarker program
PremiumThe Fly
Shuttle Pharmaceuticals licenses IP for prostate cancer biomarker program
9M ago
SHPH
Shuttle Pharmaceuticals announces results of pre-IND meeting with FDA
PremiumThe FlyShuttle Pharmaceuticals announces results of pre-IND meeting with FDA
10M ago
SHPH
Shuttle Pharmaceuticals expands patent coverage on HDAC inhibitor platform
PremiumThe Fly
Shuttle Pharmaceuticals expands patent coverage on HDAC inhibitor platform
11M ago
SHPH
Shuttle Pharmaceuticals’ HDAC6 inhibitor shows immune response stimulation
PremiumThe Fly
Shuttle Pharmaceuticals’ HDAC6 inhibitor shows immune response stimulation
11M ago
SHPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >